Effects of Phase III Cardiac Rehabilitation on Mortality and Cardiovascular Events in Elderly Patients With Stable Coronary Artery Disease

被引:19
|
作者
Onishi, Tomo [1 ,3 ]
Shimada, Kazunori [1 ,3 ]
Sato, Hiroyuki [2 ,3 ]
Seki, Eriko [1 ]
Watanabe, Yoshiro [1 ]
Sunayama, Satoshi [1 ]
Ohmura, Hirotoshi [1 ]
Masaki, Yoshiyuki [1 ]
Nishitani, Miho [1 ]
Fukao, Kosuke [1 ]
Kume, Atsumi [1 ]
Sumide, Takahiro [3 ]
Mokuno, Hiroshi [1 ]
Naito, Hisashi [3 ,4 ]
Kawai, Sachio [1 ,4 ]
Daida, Hiroyuki [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 1138421, Japan
[3] Juntendo Univ Hosp, Juntendo Sports Clin, Tokyo, Japan
[4] Juntendo Univ, Sch Hlth & Sports Sci, Dept Sports Sci, Chiba, Japan
基金
日本学术振兴会;
关键词
Cardiovascular events; Cardiac rehabilitation; Coronary artery disease; Elderly patients; Prognosis; QUALITY-OF-LIFE; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CLINICAL-TRIAL; PROGRAM J-CARP; RISK-FACTORS; EXERCISE CAPACITY; BEHAVIORAL-CHARACTERISTICS; HEART-DISEASE; FOLLOW-UP; JAPAN;
D O I
10.1253/circj.CJ-09-0638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac rehabilitation (CR) has numerous benefits, including reduction of mortality and cardiovascular events, in patients with coronary artery disease (CAD). However, the long-term effect of phase III CR in elderly patients with stable CAD is still unknown. Methods and Results: The 111 elderly male CAD patients (65 years), including 37 subjects participating in supervised CR for 6 months and 74 age-matched controls, were analyzed. The patients were followed for up to 3,500 days, until the occurrence of death or 1 of the following major adverse cardiovascular events (MACE): cardiovascular death, acute coronary syndrome, refractory angina requiring revascularization, admission for congestive heart failure, or stroke. All-cause mortality tended to be lower in the CR group than in the Control group (14% vs 28%, P=0.081). The MACE incidence was significantly lower in the CR group than in the Control group (30% vs 62%, P=0.001). Multivariate Cox proportional hazard analysis showed that the MACE incidence was significantly lower in the CR group than in the Control group [adjusted hazard ratio 0.43 (95% confidence interval 0.20-0.91), P=0.027]. Conclusions: Phase III CR has the beneficial effect of reducing cardiovascular events even in elderly patients with stable CAD. (Circ J 2010; 74: 709-714)
引用
收藏
页码:709 / 714
页数:6
相关论文
共 50 条
  • [1] Effects of Cardiac Rehabilitation on Cardiovascular Events in Elderly Patients with Stable Coronary Artery Disease
    Onishi, Tomo
    Shimada, Kazunori
    Sato, Hiroyuki
    Seki, Eriko
    Watanabe, Yoshiro
    Sunayama, Satoshi
    Ohmura, Hirotoshi
    Masaki, Yoshiyuki
    Nishitani, Miho
    Fukao, Kosuke
    Kume, Atsumi
    Sumide, Takahiro
    Mokuno, Hiroshi
    Naito, Hisashi
    Kawai, Sachio
    Daida, Hiroyuki
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 723 - 723
  • [2] Long-term effects of cardiac rehabilitation in elderly individuals with stable coronary artery disease
    Mandic, Sandra
    Stevens, Emily
    Hodge, Claire
    Brown, Casey
    Walker, Robert
    Body, Dianne
    Barclay, Leanne
    Nye, Edwin R.
    Williams, Michael J. A.
    DISABILITY AND REHABILITATION, 2016, 38 (09) : 837 - 843
  • [3] Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis
    Bertrand, Michel E.
    Ferrari, Roberto
    Remme, Willem J.
    Simoons, Maarten L.
    Fox, Kim M.
    AMERICAN HEART JOURNAL, 2015, 170 (06) : 1092 - 1098
  • [4] The effects of cardiac rehabilitation in patients with coronary artery disease
    Afrasiabi, A
    Toofan, M
    Pirzad, L
    Hassanzadeh, S
    Pirzad, H
    SAUDI MEDICAL JOURNAL, 2003, 24 (10) : 1145 - 1148
  • [5] Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease - Juntendo Cardiac Rehabilitation Program (J-CARP)
    Seki, Eriko
    Watanabe, Yoshiro
    Shimada, Kazunori
    Sunayama, Satoshi
    Onishi, Tomo
    Kawakami, Kazunobu
    Sato, Mizue
    Sato, Hiroyuki
    Mokuno, Hiroshi
    Daida, Hiroyuki
    CIRCULATION JOURNAL, 2008, 72 (08) : 1230 - 1234
  • [6] Immature platelets and cardiovascular events in patients with stable coronary artery disease
    Pedersen, Oliver Buchhave
    Larsen, Sanne Bojet
    Kristensen, Steen Dalby
    Hvas, Anne-Mette
    Grove, Erik Lerkevang
    PLATELETS, 2023, 34 (01)
  • [7] ADIPOSITY ASSOCIATED MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE
    Korenfeld, Yoel
    Albuquerque, Felipe
    Somers, Virend K.
    Qin, Rui
    Boarin, Simona
    Jarsania, Vijaykumar
    Romero-Corral, Abel
    Thomas, Randall J.
    Lopez-Jimenez, Francisco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [8] Effects of phase III cardiac rehabilitation programs on health-related quality of life in elderly patients with coronary artery disease - Juntendo cardiac rehabilitation program (J-CARP)
    Seki, E
    Watanabe, Y
    Sunayama, S
    Iwama, Y
    Shimada, K
    Kawakami, K
    Sato, M
    Sato, H
    Mokuno, H
    Daida, H
    CIRCULATION JOURNAL, 2003, 67 (01) : 73 - 77
  • [9] Effects of cardiac rehabilitation qigong exercise in patients with stable coronary artery disease undergoing phase Ⅲ rehabilitation: A randomized controlled trial(with video)
    Fengrun Zhao
    Yin Lin
    Lindan Zhai
    Can Gao
    Jianhong Zhang
    Qun Ye
    Christopher John Zaslawski
    Fangfang Ma
    Yichen Wang
    Chen Liang
    Journal of Traditional Chinese Medical Sciences, 2018, 5 (04) : 420 - 430
  • [10] Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study
    Ku, Ivy A.
    Farzaneh-Far, Ramin
    Vittinghoff, Eric
    Zhang, Mary H.
    Na, Beeya
    Whooley, Mary A.
    ATHEROSCLEROSIS, 2011, 217 (02) : 503 - 508